Your browser doesn't support javascript.
loading
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma.
Vassilakopoulos, Theodoros P; Liaskas, Athanasios; Pereyra, Patricio; Panayiotidis, Panayiotis; Angelopoulou, Maria K; Gallamini, Andrea.
Afiliação
  • Vassilakopoulos TP; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, 11527 Athens, Greece.
  • Liaskas A; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, 11527 Athens, Greece.
  • Pereyra P; Department of Hematology, National Hospital Alejandro Posadas, Buenos Aires 1684, Argentina.
  • Panayiotidis P; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, 11527 Athens, Greece.
  • Angelopoulou MK; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, 11527 Athens, Greece.
  • Gallamini A; Research and Clinical Innovation Department, Antoine Lacassagne Cancer Center, 06100 Nice, France.
Int J Mol Sci ; 24(17)2023 Aug 24.
Article em En | MEDLINE | ID: mdl-37685994

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia